GS
Girish Surajmal Pokharna
About Girish Surajmal Pokharna
Data last updated:
Girish Surajmal Pokharna is a Director at Surat Lifecare Private Limited (since 2012), Director at Torin Pharmaceuticals Private Limited (since 2022) and Director at Ohm Mri Private Limited (since 2024), and holds 1 more current directorship. The companies operate in Healthcare, Pharma and Life Sciences. The 4 current companies with reported revenue have a combined latest revenue of ₹36.99 Cr; the largest is Surat Lifecare Private Limited at ₹32.08 Cr (FY 2024). Earlier, Girish Surajmal Pokharna was a Director at Brig Diagnostics Private Limited (2002–2020) and Designated Partner at Surat Medicare Llp (2013–2018) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Dec 2012 | 2012 | ₹32.08 Cr (FY 2024) | Active | |
| Director | 17 Jan 2022 | 2021 | ₹3.34 Cr (FY 2025) | Active | |
| Director | 10 Jan 2024 | 2022 | ₹1.47 Cr (FY 2024) | Active | |
| Director | 20 Jan 2004 | 2004 | ₹10.5 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Jan 2002 | 2002 | Converted To Llp | ||
| Designated Partner | 19 Mar 2013 | 2013 | Active | ||
| Designated Partner | 20 Feb 2020 | 2020 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Girish Surajmal Pokharna
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Girish Surajmal Pokharna
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Girish Surajmal Pokharna
Girish Surajmal Pokharna currently holds 4 directorships: Surat Lifecare Private Limited (Director, since 10 Dec 2012, revenue ₹32.08 Cr (FY 2024)); Torin Pharmaceuticals Private Limited (Director, since 17 Jan 2022, revenue ₹3.34 Cr (FY 2025)); Ohm Mri Private Limited (Director, since 10 Jan 2024, revenue ₹1.47 Cr (FY 2024)); Surat Dexa Scan Private Limited (Director, since 20 Jan 2004, revenue ₹10.5 Lakh (FY 2024)).
Girish Surajmal Pokharna was first appointed on 16 Jan 2002 as Director at Brig Diagnostics Private Limited. The most recent appointment on record is 10 Jan 2024 at Ohm Mri Private Limited.
The 4 current companies of Girish Surajmal Pokharna that report revenue have a combined latest revenue of ₹36.99 Cr: Surat Lifecare Private Limited ₹32.08 Cr (FY 2024); Torin Pharmaceuticals Private Limited ₹3.34 Cr (FY 2025); Ohm Mri Private Limited ₹1.47 Cr (FY 2024); Surat Dexa Scan Private Limited ₹10.5 Lakh (FY 2024).
Girish Surajmal Pokharna held 3 earlier board appointments: Brig Diagnostics Private Limited (Director, 16 Jan 2002 to 19 Feb 2020); Surat Medicare Llp (Designated Partner, 19 Mar 2013 to 01 Apr 2018); Brig Diagnostics Llp (Designated Partner, from 20 Feb 2020).
The current boards of Girish Surajmal Pokharna's companies include Bharat Bhikhabhai Sutariya (Surat Lifecare Private Limited), Chandrakant Dulhadinomal Lalwani (Surat Lifecare Private Limited), Farida Hoshang Wadia (Surat Lifecare Private Limited), Harin Hemeshbhai Modi (Surat Lifecare Private Limited), Hitesh Thakorbhai Patel (Surat Lifecare Private Limited), Indu Nareshkumar Arora (Surat Lifecare Private Limited), among others.